
Aakash Desai/LinkedIn
Mar 25, 2025, 17:52
Aakash Desai: Interesting innovation in colon cancer therapy
Aakash Desai, Associate Director of Phase 1 and Precision Oncology Program at UAB O’Neal Comprehensive Cancer Center, shared an article by Yixuan Liu, et al. on X:
“Interesting innovation in cancer therapy
Nature Communications reported a protease-cleavable liposome that co-delivers anti–PD-L1 and doxorubicin directly to tumors in mice.
- Tumor penetration
- Immune activation
- Targeted drug release”
A protease-cleavable liposome for co-delivery of anti-PD-L1 and doxorubicin for colon cancer therapy in mice.
Authors: Yixuan Liu, et al.
More posts featuring Colon Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 28, 2025, 17:15
Mar 28, 2025, 17:05
Mar 28, 2025, 16:56
Mar 28, 2025, 15:54